Dog Feeding

NuGen M.D. Launches PetJet(TM) Offering Needle-Free Injections for Domesticated Pets

Decreasing Worry and Threat of Damage for Pet Homeowners and their Furry Beloved Ones

TORONTO, ON / ACCESSWIRE / June 22, 2022 /NuGen Medical Units Inc. (TSXV:NGMD) (“NuGen” or the “Firm”), a frontrunner in needle-free drug supply, is happy to announce that it is going to be launching a needle-free injection machine particularly designed for domesticated family pets.

The PetJetTM will permit pet homeowners and veterinarians to soundly and shortly inject numerous kinds of remedy with out the worry of injuring their pets with a conventional hypodermic needle.

Seventy p.c of U.S. households, or about 90.5 million households, personal a pet, in line with the 2021-2022 Nationwide Pet Homeowners Survey carried out by the American Pet Merchandise Affiliation (APPA). That is up from 56 p.c of U.S. households in 1988, the primary yr the survey was carried out, and 67 p.c in 2019.

As in people, canine and cats with diabetes usually require lifelong therapy which can embrace day by day injections of insulin. Based on the American Veterinary Medical Affiliation (AVMA), diabetes can happen in cats and canine of any age, though it’s usually recognized later within the animal’s life and, if not handled with correct insulin and feeding schedules, might trigger long-term hurt to the pet.

Michael Wright, CEO of NuGen M.D. states, “Our needle-free answer presents extra than simply improved well being care alternatives in people, however brings a much-needed answer for the hundreds of thousands of domesticated pets affected by continual sickness in North America. Whereas diabetes is a rising concern and value in people, additionally it is in pets. Our machine can be utilized 5,000 occasions throughout many drugs to be used in pets. It may be devastating for a loving pet proprietor to jab their pets day by day or weekly so as to administer lifesaving remedy. Nevertheless, with PetJet™, these pet homeowners will be capable to ship the remedy with out the destructive associations of hypodermic needles.”

In 2016, the State of Pet Well being Report discovered that diabetes is on the rise in each canine and cats, with diagnoses rising practically 80% in canine and 18% in cats over a 10-year interval. At the moment, about one in each 300 canine and one in 230 cats are recognized with diabetes throughout their lifetimes, though analysis means that many circumstances nonetheless go undiagnosed.

Story continues

Just like the NuGen M.D. needle-free injection system, also called InsuJet™, which is a self-administered needle-free injection system permitted by Well being Canada and in over 40 different international locations globally, the PetJet™ could be safely used 5,000 occasions with out the chance of needle-stick harm or cross-contamination in addition to eliminating the waste administration of sharps (used needles), making it simpler for homeowners to supply at-home care to their pets.

For veterinarians, the PetJet™ presents a substitute for hypodermic needles that current actual risks like needlestick accidents, which could be completely damaging, life altering, and have gotten extra of a priority amongst veterinary medication professionals. The Veterinary Medicines Directorate (VMD) has reported a number of circumstances of long-term points from veterinary needlestick harm together with extended ache, irritation, and restrictions to mobility.

About NuGen Medical Units

NuGen Medical Units’ principal enterprise is the event and commercialization of modern needle-free injection gadgets and methods for the administration of subcutaneous remedy.

It’s growing merchandise utilizing needle-free drug supply know-how in a number of vital fields together with, however not restricted to, anaphylaxis, diabetes, extreme migraine, erectile dysfunction, continual anemia, neutropenia, autoimmune rheumatoid arthritis, development and fertility hormone, psoriasis in addition to DNA and standard/pediatric vaccines.

For Extra Data go to:
Twitter: @NuGenMD

For additional info, please contact:
Michael Wright
President and CEO
NuGen Medical Units Inc.

Investor Relations Contact:
Kin Communications Inc.
(604) 684-6730
Twitter: @KinComm

Neither TSX Enterprise Trade nor its Regulation Providers Supplier (as that time period is outlined in insurance policies of the TSX Enterprise Trade) accepts accountability for the adequacy or accuracy of this launch.

This information launch incorporates forward-looking info which is topic to a wide range of dangers and uncertainties and different components that might trigger precise occasions or outcomes to vary from these projected within the forward-looking statements. Ahead wanting statements on this press launch embrace the Firm’s 2022 aims of securing further distribution and gross sales agreements, making submissions for regulatory approvals and capitalizing on further market alternatives. These forward-looking statements are topic to a wide range of dangers and uncertainties and different components that might trigger precise occasions or outcomes to vary materially from these projected within the forward-looking info. The forward-looking info contained herein is given as of the date hereof and the Firm assumes no accountability to replace or revise such info to mirror new occasions or circumstances, besides as required by legislation.

SOURCE: NuGen Medical Units

View supply model on

Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *